Patient Leaflet Updated 28-Jul-2025 | Ferring Pharmaceuticals Ltd
Pentasa Suppositories 1
PENTASA®
Suppositories 1g
Mesalazine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
1. What Pentasa Suppository is and what it is used for
2. What you need to know before you use Pentasa Suppository
3. How to use Pentasa Suppository
4. Possible side effects
5. How to store Pentasa Suppository
6. Contents of the pack and other information
Each Pentasa Suppository contains mesalazine 1g as the active ingredient. Mesalazine belongs to a group of medicines called salicylates.
Pentasa is used to treat inflammation in the gut caused by conditions such as ulcerative colitis. Sometimes ulcerative colitis only affects the back passage (rectum), this is known as ulcerative proctitis. Pentasa Suppositories are used to treat ulcerative proctitis and are intended for rectal use only. The suppositories release the active ingredient slowly which then acts locally to reduce the inflammation and help relieve or stop the pain.
Talk to your doctor or pharmacist before using these suppositories if you:
Mezalazine may produce red-brown urine discoloration after contact with sodium hypochlorite bleach in the toilet water. It concerns a chemical reaction between mesalazine and bleach and is harmless.
Serious skin reactions including Drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported in association with mesalazine treatment. Stop using Pentasa Suppository and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
If you experience strong or recurrent headache, disturbed vision, or ringing or buzzing in the ears contact your doctor immediately.
While you are on treatment with this medicine, your doctor will normally arrange blood and urine tests to check your kidney function especially at the beginning of treatment.
You should make sure that you don’t become dehydrated, while you are using this medicine. This can occur after severe or prolonged attacks of vomiting and/or diarrhoea, high fever or heavy sweating. If this occurs, you should talk to your doctor or a pharmacist for advice as soon as possible.
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This is especially important if you are taking any of the following:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
There is limited experience with the use of mesalazine during pregnancy and breast-feeding. Blood disorders have been reported in newborns of mothers being treated with this medicine. The newborn may develop allergic reactions after breast-feeding, e.g. diarrhoea. If the newborn develops diarrhoea, breast-feeding should be discontinued.
This medicine is not known to affect the ability to drive and/or use machines.
For Adult use only, not recommended in children. Always use Pentasa exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
The suppository should be inserted into the back passage (rectum) only. It is intended to be left in place for as long as possible and is therefore best inserted before going to sleep. To treat an attack of proctitis your doctor will usually prescribe one suppository to be used daily for two to four weeks. To help prevent further attacks it may be used for longer.
How to insert the suppository
You should make sure that you empty your bowels before inserting the suppository.
a. Tear along the perforation to remove one suppository blister from a blister strip
b. Put a protector on the finger with which you will insert the suppository
c. Remove the suppository from the blister before insertion. This is done by pushing the suppository through the printed foil
d. Insertion may be made easier if you moisten the suppository with water first
e. Insert the suppository gently and fully into the back passage. It may help to lie down on one side and raise the other knee.
f. Remain still for a few minutes after insertion to help keep the suppository in place. If it comes out within 10 minutes, a new one should be inserted
g. Dispose of the empty blister and used finger protector safely and wash your hands.
If you accidentally use too many suppositories, you should go to your nearest emergency department or contact your doctor immediately. Take the pack and any remaining suppositories with you.
If you forget to use a dose, use the next dose as soon as you remember, unless it is less than 6 hours until your next dose.
Do not use a double dose to make up for the forgotten one.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Pentasa can cause side effects, although not everyone gets them. Following rectal administration local reactions such as itching, rectal discomfort and urge may occur.
If you experience any of the above side effects, you should contact your doctor or go to the nearest hospital emergency department immediately.
The following common side effects may affect up to 1 in 10 people:
The following rare side effects may affect up to 1 in 1,000 people:
The following very rare side effects may affect up to 1 in 10,000 people:
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister. The expiry date refers to the last day of that month.
Do not store above 25ºC.
Store in the original packaging.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Each suppository contains 1g of the active ingredient, mesalazine. It also contains the following inactive ingredients: povidone, magnesium stearate, macrogol and talc.
The suppositories are oblong, compressed, white to light tan speckled suppositories. Each carton contains 28 suppositories presented in blister strips of 7 suppositories per strip, together with 28 finger protectors for use when inserting the suppository.
This leaflet was last revised in May 2025.
PENTASA is a registered trademark.
Drayton Hall, Church Road, West Drayton, UB7 7PS, UK
+44 (0)844 931 0051
http://www.ferring.co.uk
+44 (0)844 931 0050
0800 111 4125